Don't accept
second best.
See why Dexcom is the
#1 preferred CGM among
Canadian Endocrinologists

Complete this form to order a sample of Dexcom G7 today.
CGM = continuous glucose monitoring.
* Based on a survey of Canadian endocrinologists (n=41).
† Based on commercially available CGM systems as of May 1, 2025.
‡ Audible and visual notification of predictive alert at 3.1 mmol/L within 20 minutes.
1 dQ&A, Dexcom Canadian Endos Report Wave 1 2024.
2 Dexcom, Data on file, 2025.
3 Beck RW, et al. JAMA. 2017;317(4):371-378.
4 Beck RW, et al. Ann Intern Med. 2017;167(6) 365-374.
5 Martens T, et al. JAMA. 2021;325(22):2262-2272.
6 Leffel LM, et al. JAMA. 2020;323(23):2388-2396.
7 Welsh JB, et al. J Diabetes Sci Technol. 2024;18(1):143-147.
8 Dexcom G7 User Guide.
Dexcom and Dexcom G7 are registered trademarks of Dexcom, Inc. in the U.S. and may be registered in other countries.© 2025 Dexcom Canada, Co. All rights reserved. MAT-8255 Vl.0